DE3851203T2 - Gebrauch von GHL-Cu Derivaten für die Herstellung eines Medikaments zur Stimulierung des Haarwachstums. - Google Patents

Gebrauch von GHL-Cu Derivaten für die Herstellung eines Medikaments zur Stimulierung des Haarwachstums.

Info

Publication number
DE3851203T2
DE3851203T2 DE3851203T DE3851203T DE3851203T2 DE 3851203 T2 DE3851203 T2 DE 3851203T2 DE 3851203 T DE3851203 T DE 3851203T DE 3851203 T DE3851203 T DE 3851203T DE 3851203 T2 DE3851203 T2 DE 3851203T2
Authority
DE
Germany
Prior art keywords
ghl
medicament
derivatives
manufacture
hair growth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3851203T
Other languages
English (en)
Other versions
DE3851203D1 (de
Inventor
Loren Pickart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procyte Corp
Original Assignee
Procyte Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procyte Corp filed Critical Procyte Corp
Publication of DE3851203D1 publication Critical patent/DE3851203D1/de
Application granted granted Critical
Publication of DE3851203T2 publication Critical patent/DE3851203T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/58—Metal complex; Coordination compounds
DE3851203T 1987-05-11 1988-05-11 Gebrauch von GHL-Cu Derivaten für die Herstellung eines Medikaments zur Stimulierung des Haarwachstums. Expired - Fee Related DE3851203T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4844487A 1987-05-11 1987-05-11
PCT/US1988/001555 WO1988008695A1 (en) 1987-05-11 1988-05-11 Methods for stimulating hair growth

Publications (2)

Publication Number Publication Date
DE3851203D1 DE3851203D1 (de) 1994-09-29
DE3851203T2 true DE3851203T2 (de) 1994-12-15

Family

ID=21954621

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3851203T Expired - Fee Related DE3851203T2 (de) 1987-05-11 1988-05-11 Gebrauch von GHL-Cu Derivaten für die Herstellung eines Medikaments zur Stimulierung des Haarwachstums.

Country Status (11)

Country Link
US (1) US5135913A (de)
EP (1) EP0314755B1 (de)
JP (2) JP2604457B2 (de)
KR (1) KR960014776B1 (de)
AT (1) ATE110255T1 (de)
CA (1) CA1323839C (de)
DE (1) DE3851203T2 (de)
DK (1) DK10389D0 (de)
MX (1) MX169205B (de)
NO (1) NO175616C (de)
WO (1) WO1988008695A1 (de)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5348943A (en) * 1985-02-08 1994-09-20 Procyte Corporation Cosmetic and skin treatment compositions
US5120831A (en) * 1985-02-08 1992-06-09 Procyte Corporation Metal-peptide compositions
WO1989012441A1 (en) * 1988-06-16 1989-12-28 Procyte Corporation Cosmetic and skin treatment compositions
US5118665A (en) * 1990-02-09 1992-06-02 Procyte Corporation Anti-oxidative and anti-inflammatory metal:peptide complexes and uses thereof
US5164367A (en) * 1990-03-26 1992-11-17 Procyte Corporation Method of using copper(ii) containing compounds to accelerate wound healing
US5252559A (en) * 1991-08-20 1993-10-12 The Procter & Gamble Company His-Gly-Gly peptide and derivatives thereof for hair growth
ATE365530T1 (de) * 1992-07-13 2007-07-15 Shiseido Co Ltd Retinolthaltiges, stabilisiertes hautpflegemittel zur äusserlichen anwendung
US5382431A (en) * 1992-09-29 1995-01-17 Skin Biology, Inc. Tissue protective and regenerative compositions
ES2101263T3 (es) 1993-02-19 1997-07-01 Howard Green Composiciones que contienen proteinas de corneocitos.
US5425954A (en) * 1993-09-30 1995-06-20 Curafas Incorporated Topical amino acid - vitamin complex compositions for pharmaceutical and cosmetic use
CA2186448A1 (en) * 1994-03-28 1995-10-05 Loren R. Pickart Starch-metal complexes for skin and hair
US5538945A (en) * 1994-06-17 1996-07-23 Procyte Corporation Stimulation of hair growth by peptide copper complexes
US5735212A (en) * 1994-08-09 1998-04-07 Baldwin-Japan Ltd. Cylinder cleaning apparatus
FR2733421B1 (fr) * 1995-04-28 1997-06-06 Oreal Utilisation de derives de l'hormone stimulatrice des melanocytes de type alpha pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute
US6001812A (en) * 1995-04-28 1999-12-14 Societe L'oreal S.A. Modulating body/cranial hair growth with derivatives of the α-type melanocyte-stimulating hormone
US5614489A (en) * 1995-05-25 1997-03-25 Mohammadi; Fatemeh Method and composition for treating the skin
US5866142A (en) * 1995-07-20 1999-02-02 Riordan; Neil H. Skin treatment system
US5888522A (en) * 1996-08-23 1999-03-30 Skin Biology, Inc. Tissue protective and regenerative compositions
US6958148B1 (en) 1998-01-20 2005-10-25 Pericor Science, Inc. Linkage of agents to body tissue using microparticles and transglutaminase
US6919076B1 (en) 1998-01-20 2005-07-19 Pericor Science, Inc. Conjugates of agents and transglutaminase substrate linking molecules
CA2318661A1 (en) 1998-01-20 1999-07-22 Howard Green Transglutaminase linkage of agents to tissue
EP1061964B2 (de) * 1998-03-12 2009-10-28 The Procter & Gamble Company Protonendonatoren in saugkörpern
US7632803B2 (en) * 1999-10-01 2009-12-15 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
US20030130185A1 (en) * 2000-09-29 2003-07-10 David Bar-Or Metal-binding compounds and uses therefor
US7592304B2 (en) 1999-10-01 2009-09-22 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
JP5349722B2 (ja) 1999-10-01 2013-11-20 ディーエムアイ バイオサイエンシズ インコーポレイテッド 金属結合化合物およびその使用方法
KR100688910B1 (ko) * 2000-07-06 2007-03-08 주식회사 코리아나화장품 트리펩타이드 함유 립스틱 조성물
US20030166510A1 (en) * 2000-10-11 2003-09-04 Pickart Loren R. Methods and compositions for increasing skin remodeling
FR2826580B1 (fr) * 2001-06-29 2005-09-30 Oreal Utilisation du tripeptide lys-pro-val (kpv) pour favoriser le renouvellement epidermique et la micro-cicatrisation cutanee superficielle et/ou ameliorer l'aspect esthetique des plaies et cicatrices
FR2826581B1 (fr) * 2001-06-29 2005-10-07 Oreal Utilisation du tripeptide lys-pro-val (kpv) dans le traitement des melanomes
CA2462909A1 (en) * 2001-10-05 2003-06-12 Procyte Corporation Methods for the treatment of hyperpigmentation of skin
US20030134780A1 (en) * 2001-10-05 2003-07-17 Procyte Corporation Skin care compositions containing peptide copper complexes and retinol, retinol derivatives, or a mixture thereof
WO2003030926A1 (en) * 2001-10-05 2003-04-17 Procyte Corporation Stable solutions of peptide copper complexes and cosmetic and pharmaceutical formulations produced therefrom
WO2004004671A1 (en) * 2002-07-02 2004-01-15 Procyte Corporation Compositions containing peptide copper complexes and soft tissue fillers
AU2003256797A1 (en) * 2002-07-31 2004-02-25 Procyte Corporation Compositions containing peptide copper complexes and phytochemical compounds, and methods related thereto
US20040138103A1 (en) * 2002-11-07 2004-07-15 Procyte Corporation Compositions containing peptide copper complexes and metalloproteinase inhibitors and methods related thereto
FR2847269B1 (fr) * 2002-11-19 2006-07-28 Coletica Procede d'identification d'une modification eventuelle d'au moins un parametre biologique mettant en oeuvre des cellules vivantes jeunes et agees
US7128923B2 (en) 2003-03-31 2006-10-31 Procyte Corporation Preserved and stable compositions containing peptide copper complexes and method related thereto
US6927205B2 (en) * 2003-04-28 2005-08-09 Procyte Corporation Compositions and methods for treatment of psoriasis
US6927206B2 (en) * 2003-06-06 2005-08-09 Procyte Corporation Compositions and methods for treatment of rosacea
US8734421B2 (en) 2003-06-30 2014-05-27 Johnson & Johnson Consumer Companies, Inc. Methods of treating pores on the skin with electricity
FR2857667B1 (fr) 2003-07-18 2007-07-13 Inst Europ Biolog Cellulaire Nouveaux conjugues peptidiques utiles dans le traitement preventif et curatif de l'alopecie
FR2857597B1 (fr) * 2003-07-18 2008-01-25 Inst Europeen Biolog Cellulair Utilisation de conjugues peptidiques pour la preparation de compositions destinees au traitement preventif et curatif de l'alopecie.
CA2533730C (en) 2003-08-04 2013-09-24 Galileo Pharmaceuticals, Inc. Methods for treatment of dermatological conditions
US20050260275A1 (en) * 2004-04-01 2005-11-24 Procyte Corporation Encapsulated peptide copper complexes and compositions and methods related thereto
WO2006023465A1 (en) * 2004-08-18 2006-03-02 Procyte Corporation Polyethylene glycol-peptide copper complexes and compositions and methods related thereto
EP1809385B1 (de) * 2004-11-09 2009-07-15 The Cupron Corporation Verfahren und materialien für die hautpflege
US20060216258A1 (en) 2005-03-24 2006-09-28 Singleton Laura C Water-in-silicone emulsion compositions
DE102005026069A1 (de) * 2005-06-07 2006-12-14 Goldschmidt Gmbh Topische kosmetische Formulierungen zur Regulierung und Verbesserung des Feuchtigkeitsgehalts der Haut
US7897800B2 (en) 2006-02-03 2011-03-01 Jr Chem, Llc Chemical compositions and methods of making them
US7687650B2 (en) 2006-02-03 2010-03-30 Jr Chem, Llc Chemical compositions and methods of making them
CA2641420C (en) 2006-02-03 2013-06-25 Jr Chem, Llc Anti-aging treatment using copper and zinc compositions
US8728819B2 (en) 2006-08-29 2014-05-20 Fibrocell Technologies, Inc. Methods for culturing minimally-passaged fibroblasts and uses thereof
US7867522B2 (en) 2006-09-28 2011-01-11 Jr Chem, Llc Method of wound/burn healing using copper-zinc compositions
EP2065029B1 (de) 2007-11-30 2013-04-17 Evonik Goldschmidt GmbH Körperpflege- und Kosmetikzusammensetzung mit Tetrapeptiden mit den Motiven GX1X2G, PX1X2P oder PX1X2K
US8273791B2 (en) 2008-01-04 2012-09-25 Jr Chem, Llc Compositions, kits and regimens for the treatment of skin, especially décolletage
US20160184354A1 (en) 2009-01-23 2016-06-30 Jr Chem, Llc Rosacea treatments and kits for performing them
US20120089232A1 (en) 2009-03-27 2012-04-12 Jennifer Hagyoung Kang Choi Medical devices with galvanic particulates
CN102781406B (zh) 2010-03-01 2015-07-08 强生消费者公司 具有理想的整体颜色的护肤组合物
US8952057B2 (en) 2011-01-11 2015-02-10 Jr Chem, Llc Compositions for anorectal use and methods for treating anorectal disorders
EP3542866A1 (de) * 2012-03-07 2019-09-25 Fibrocell Technologies, Inc. Topische dermale formulierungen und verfahren zur personalisierten hautbehandlung
TWI444197B (zh) * 2012-04-26 2014-07-11 Univ China Medical 用於改善皮膚老化之組合物
ITRM20130199A1 (it) 2013-04-03 2014-10-04 Irbm Science Park S P A Peptidi per uso dermatologico e/o cosmetico

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3194732A (en) * 1960-10-03 1965-07-13 Neuhauser Irene Assisting healing of skin-denuded areas on the body with dried non-fibrous egg-shellmembrane products and compositions therefor
US3558770A (en) * 1967-09-01 1971-01-26 Kraftco Corp Wound treating composition employing an enzyme modified casein
US3551554A (en) * 1968-08-16 1970-12-29 Crown Zellerbach Corp Enhancing tissue penetration of physiologically active agents with dmso
US3767784A (en) * 1970-12-01 1973-10-23 S Gluck Composition for the protection and treatment of injured body tissue and method of utilizing the same
US3832338A (en) * 1972-03-23 1974-08-27 Diagnostic Data Inc Orgotein production using a buffer solution containing divalent metal salts
US3758682A (en) * 1972-03-23 1973-09-11 Diagnostics Data Inc Pharmaceutical compositions comprising orgotein and their use
US4022888A (en) * 1975-09-09 1977-05-10 Diagnostic Data, Inc. Esterified orgotein
DE2700043C2 (de) * 1977-01-03 1983-12-08 Thera Gesellschaft für Patentverwertung mbH, 8036 Herrsching Mittel zur Verbesserung der Durchblutung und Wundheilung
US4167945A (en) * 1977-01-31 1979-09-18 Gottlieb Sheldon K Method for enhancing the healing of grafted tissue
US4287184A (en) * 1977-11-23 1981-09-01 The Massachusetts General Hospital Process for healing wounds
US4263428A (en) * 1978-03-24 1981-04-21 The Regents Of The University Of California Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same
US4440788A (en) * 1980-05-13 1984-04-03 Mitsubishi Chemical Industries, Limited Cysteine derivatives
HU193289B (en) * 1984-06-19 1987-09-28 Universal Vegyipari Szoevetkez Cosmetical composition for treating hair and nail containing blood plasma concentrate as active agent
US4760051A (en) * 1985-01-24 1988-07-26 Pickart Loren R Use of GHL-Cu as a wound-healing and anti-inflammatory agent
US4665054A (en) * 1985-02-08 1987-05-12 Bioheal, Inc. Chemical derivatives of GHL-Cu

Also Published As

Publication number Publication date
JP2988876B2 (ja) 1999-12-13
WO1988008695A1 (en) 1988-11-17
DE3851203D1 (de) 1994-09-29
EP0314755A1 (de) 1989-05-10
NO175616C (no) 1994-11-09
ATE110255T1 (de) 1994-09-15
JP2604457B2 (ja) 1997-04-30
US5135913A (en) 1992-08-04
DK10389A (da) 1989-01-11
AU609819B2 (en) 1991-05-09
JPH09278631A (ja) 1997-10-28
NO890089D0 (no) 1989-01-10
MX169205B (es) 1993-06-24
DK10389D0 (da) 1989-01-11
CA1323839C (en) 1993-11-02
EP0314755B1 (de) 1994-08-24
KR960014776B1 (en) 1996-10-19
JPH02500367A (ja) 1990-02-08
NO890089L (no) 1989-01-10
NO175616B (de) 1994-08-01
AU1729688A (en) 1988-12-06
KR890701079A (ko) 1989-12-19

Similar Documents

Publication Publication Date Title
DE3851203D1 (de) Gebrauch von GHL-Cu Derivaten für die Herstellung eines Medikaments zur Stimulierung des Haarwachstums.
GR1002802B (el) Καλλυντικες συνθεσεις και συνθεσεις περιποιησεως του δερματος
DE3777253D1 (de) Herzschrittmacher zur stimulierung des menschlichen herzens.
DE3860043D1 (de) Verwendung von biertreberextrakt zur herstellung von medizinischen und kosmetischen zubereitungen.
DE3778585D1 (de) Herzschrittmacher zur stimulierung des menschlichen herzens.
SE7902742L (sv) Disubstituerade 3-cefem-4-karboxylsyraderivat samt forfarande for framstellning derav
ATE108658T1 (de) Verwendung von tetracycline zur herstellung eines arzneimittels zum herabsetzen des augendrucks.
PT71408A (de) Verfahren zur herstellung von 1-alkadien-2,4-yl-2-hidroxymethyl-3,4,5-trimydroxypiperidinen mit wirkung uber die kohlehydraten und/oder fettwechsel und von diesen verbindungen enthaltenden pharmazeutischen und/oder tierartzleichen praparaten
DK137589A (da) Salicylsyreholdigt middel til behandling af hudsygdomme
DE3373978D1 (en) Composition for the care or treatment of the human skin
ATE91230T1 (de) Mittel zur nagel-, haut- und haarpflege.
AT298664B (de) Verfahren zur Herstellung von Leitschienen aus menschlichen oder tierischen Geweben zur Wiederherstellung beschädigter oder zerstörter spezifischer Gewebsteile im menschlichen und tierischen Körper
GR3001793T3 (en) Polyprenyl alcohol-containing injections and use thereof
ATE38773T1 (de) Biologisches mittel zur behandlung der haare und der haut.
ATE70444T1 (de) Topische methotrexatzubereitung zur behandlung hyperproliferativer epithelerkrankungen.
DE3276786D1 (en) Medical process and preparation
DE3765916D1 (de) Sonde zur einfuehrung in den verdauungs- oder ausscheidungstrakt des menschlichen oder tierischen koerpers, insbesondere lithotriptor-sonde.
ATE158719T1 (de) Verwendung von hexetidin oder dessen derivaten oder salzen zur herstellung einer pharmazeutischen zusammensetzung für ophthalmische verwendung
DE3280419T2 (de) Medizinisches praeparat zur behandlung von hautleiden.
DE3579642D1 (de) Zusammensetzung zur herstellung eines arzneimittels zur therapeutischen behandlung von hauttrauma.
SE8601421D0 (sv) Haarbehandlungsmittel und verfahren zur kosmetischen behandlung von haaren und haarboden
PT80062B (en) Process for the preparation of compositions to stimulate the growth of the hair
ATE56360T1 (de) Zusammensetzung zur herstellung eines arzneimittels zur therapeutischen behandlung von hauttrauma.
AR220955Q (es) Protesis de valvula cardiaca de cuspides multiples y metodo para producirla
IT8220835A0 (it) Preparazione di soluzioni iniettabili di actinina impiegabili nella terapia umana come antalgico per il trattamento del dolore da neoplasie ed altre affezioni.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee